VMP 35935911000001108

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Rotigotine 4mg/24hours transdermal patches
BNF code 0409010Z0AAABAB
Virtual Therapeutic Moiety Rotigotine
Date identifier became valid 22 Oct 2018
Previous product identifier 425670005
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 18 Jul 2008
Previous name Rotigotine 4mg/24hours patches
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units patch
Unit dose unit of measure patch
Virtual Product Ingredient
Ingredient Rotigotine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 4.000
Strength value numerator unit mg
Strength value denominator 24.000
Strength value denominator unit hour
Ontology Drug Form & Route
Form & Route patch.transdermal
Dose Form
Formulation Transdermal patch
Drug Route
Route Transdermal
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Neupro 4mg/24hours transdermal patches (Abacus Medicine Ltd)
Neupro 4mg/24hours transdermal patches (CST Pharma Ltd)
Neupro 4mg/24hours transdermal patches (Ethigen Ltd)
Neupro 4mg/24hours transdermal patches (Lexon (UK) Ltd)
Neupro 4mg/24hours transdermal patches (Sigma Pharmaceuticals Plc)
Neupro 4mg/24hours transdermal patches (UCB Pharma Ltd)
Virtual Medicinal Product Packs
Rotigotine 4mg/24hours transdermal patches 28 patch
Rotigotine 4mg/24hours transdermal patches 7 patch

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback